de Jong EMGJ - Search Results

1

A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).

Reich K, Zschocke I, Bachelez H, de Jong EMGJ, Gisondi P, Puig L, Warren RB, Ortland C, Mrowietz U; PSO-TOP study group. Reich K, et al. Among authors: de jong emgj. Br J Dermatol. 2017 Jul;177(1):197-205. doi: 10.1111/bjd.15466. Epub 2017 Jun 6. Br J Dermatol. 2017. PMID: 28301043 Clinical Trial.

2

Topical application of 13-cis-retinoic acid in the treatment of chronic plaque psoriasis.

Bischoff R, De Jong EM, Rulo HF, Sendagorta E, Czarnetzki BM, Van de Kerkhof PC. Bischoff R, et al. Clin Exp Dermatol. 1992 Jan;17(1):9-12. doi: 10.1111/j.1365-2230.1992.tb02523.x. Clin Exp Dermatol. 1992. PMID: 1424269 Clinical Trial.

3

Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations.

de Jong EM, van de Kerkhof PC. de Jong EM, et al. Br J Dermatol. 1991 Mar;124(3):221-9. doi: 10.1111/j.1365-2133.1991.tb00565.x. Br J Dermatol. 1991. PMID: 2018728 Clinical Trial.

4

Coexistence of palmoplantar lichen planus and lupus erythematosus with response to treatment using acitretin.

De Jong EM, Van De Kerkhof PC. De Jong EM, et al. Br J Dermatol. 1996 Mar;134(3):538-41. Br J Dermatol. 1996. PMID: 8731684 Free article.

5

Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients.

de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. de Jong EM, et al. Dermatology. 1996;193(4):300-3. doi: 10.1159/000246274. Dermatology. 1996. PMID: 8993953

6

The course of psoriasis.

de Jong EM. de Jong EM. Clin Dermatol. 1997 Sep-Oct;15(5):687-92. doi: 10.1016/s0738-081x(97)00023-0. Clin Dermatol. 1997. PMID: 9313967 Review. No abstract available.

7

Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis.

Van Pelt JP, De Jong EM, Seijger MM, Van Hooijdonk CA, De Bakker ES, Van Vlijmen IM, Parker GL, Van Erp PE, Van De Kerkhof PC. Van Pelt JP, et al. Br J Dermatol. 1998 Sep;139(3):396-402. doi: 10.1046/j.1365-2133.1998.02401.x. Br J Dermatol. 1998. PMID: 9767282 Clinical Trial.

8

The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.

de Jong EM, Mørk NJ, Seijger MM, De La Brassine M, Lauharanta J, Jansen CT, Guilhou JJ, Guillot B, Ostrojic A, Souteyrand P, Vaillant L, Barnes L, Rogers S, Klaber MR, Van De Kerkhof PC. de Jong EM, et al. Br J Dermatol. 2003 Feb;148(2):318-25. doi: 10.1046/j.1365-2133.2003.05173.x. Br J Dermatol. 2003. PMID: 12588386 Clinical Trial.

9

The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.

Vissers WH, Berends M, Muys L, van Erp PE, de Jong EM, van de Kerkhof PC. Vissers WH, et al. Exp Dermatol. 2004 Feb;13(2):106-12. doi: 10.1111/j.0906-6705.2004.00151.x. Exp Dermatol. 2004. PMID: 15009104 Clinical Trial.

10

A phase II multicenter clinical trial of systemic bexarotene in psoriasis.

Smit JV, Franssen ME, de Jong EM, Lambert J, Roseeuw DI, De Weert J, Yocum RC, Stevens VJ, van De Kerkhof PC. Smit JV, et al. J Am Acad Dermatol. 2004 Aug;51(2):249-56. doi: 10.1016/j.jaad.2002.08.001. J Am Acad Dermatol. 2004. PMID: 15280844 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters